AR and non-small cell lung carcinoma: Together, these results support the hypothesis that DHEA could play a role in the immune system’s response to ICI therapy in the upfront setting for metastatic NSCLC and suggest a rationale to explore potential immune checkpoint and androgen receptor dual blockade in NSCLC.